WPG Advisers
KURA icon

WPG Advisers’s Kura Oncology KURA Stock Holding History

WPG Advisers’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-83
Closed -$911 – 1624
2026
Q2 		$911 Buy
+83
New +$783 ﹤0.01% 1348
2026
Q1 		– Sell
-129
Closed -$1.34K – 1515
2025
Q4 		$1.34K Buy
+129
New +$1.35K ﹤0.01% 1235

Other funds holding KURA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

WPG Advisers's KURA Position: Q3 2026 in Review

WPG Advisers sold out of Kura Oncology (KURA) in Q3 2026, closing a stake of 83 shares — an estimated $911 sold.

WPG Advisers first reported a position in KURA in Q4 2025 and held it in 2 quarters. The position peaked at $1.34K in Q4 2025. 108 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • WPG Advisers reported no remaining Kura Oncology position as of Q3 2026 after selling out during the quarter.
  • WPG Advisers sold 83 Kura Oncology shares in Q3 2026, an estimated $911.
  • WPG Advisers first reported a position in Kura Oncology in Q4 2025 and held it in 2 quarters.
  • WPG Advisers's Kura Oncology position peaked at $1.34K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on WPG Advisers's 13F filing for Q3 2026, filed 27 Oct 2026.